A Broad Safety Assessment of the 9-Valent Human Papillomavirus Vaccine

Surveys of mother and father point out security is their high concern about human papillomavirus (HPV) vaccination. A data-mining methodology not requiring pre-specification of well being final result(s) of curiosity or post-exposure interval(s) of probably elevated danger can examine for associations between an publicity and any of 1000’s of medically attended well being outcomes. The methodology was utilized to the 9-valent HPV vaccine (HPV9) to detect potential security issues. Data on 9-26-year-olds who had obtained HPV9 vaccine between November 4, 2016 and August 5, 2018, inclusive, have been extracted from Marketscan and analyzed for statistically important clustering of incident diagnoses inside the hierarchy of ICD-10-CM coded diagnoses and temporally inside the 1 yr after vaccination, utilizing the self-controlled tree-temporal scan statistic and TreeScan software program.

Only 56 days of post-vaccination enrollment was required; subsequent follow-up was censored at disenrollment. Multiple testing was adjusted for. The evaluation included 493,089 doses of HPV9. Almost all alerts resulted from temporal confounding, not sudden with a 1-year follow-up interval. The solely believable alerts have been for non-specific adversarial occasions (e.g., injection-site reactions and headache) on Days 1-2 after vaccination, with attributable dangers as little as 1 per 100,000 vaccinees. Considering the broad scope of the analysis and the excessive statistical energy, the findings of no particular critical adversarial occasions ought to present reassurance about this vaccine’s security.

Patients present process (chemo) radiotherapy for oropharyngeal squamous cell carcinoma (OPSCC) are at excessive danger of malnutrition throughout and after therapy. Malnutrition can result in poor tolerance to therapy, therapy interruptions, poor high quality of life (QOL) and probably diminished survival fee. Human papillomavirus (HPV) is now generally known as the main trigger of OPSCC. However, analysis relating to its impact on dietary outcomes is proscribed. The purpose of this research was to look at the relationship between HPV standing and dietary outcomes, together with malnutrition and weight reduction throughout and after sufferers’ (chemo) radiotherapy therapy for OPSCC.

Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation

Diagnosed in additional than 90% of cervical cancers, the fourth deadliest most cancers in ladies, human papillomavirus (HPV) is at the moment the commonest pathogen accountable for feminine cancers. Moreover, HPV an infection is related to many different ailments, together with cutaneous and anogenital warts, and genital and higher aerodigestive tract cancers. The incidence and prevalence of these pathologies fluctuate significantly relying on components together with HPV genotype, regional situations, the research inhabitants, and the anatomical web site sampled. Recently, options of the cervicovaginal microbiota are discovered to be related to the incidence of HPV-related ailments, presenting a novel method to establish high-risk ladies by way of each blood and cervical samples.

Overall, the HPV repartition information present that HPV an infection and associated ailments are extra prevalent in creating nations. Moreover, the out there (2-, 4-, and 9-valent) vaccines based mostly on virus-like particles, regardless of their confirmed effectiveness and security, current some limitations in phrases of system improvement price, transport chilly chain, and oncogenic HPV variants. In addition, vaccination applications face some challenges, resulting in a substantial burden of HPV an infection and associated ailments. Therefore, although the new (9-valent) vaccine appears promising, next-generation vaccines in addition to consciousness applications related to HPV vaccination and price range reinforcements for immunization are wanted.

Clinical traits and tumors of 119 NSND with HNSCC have been retrospectively collected and analyzed on tissue microarrays. RNAscope in situ hybridization (ISH) was used to display for the presence of HPV and MCPyV mRNA. Immunohistochemistry was carried out for expression of p16 as surrogate marker for HPV, Large T-antigen for MCPyV, and cell cycle proteins p53 and pRb. Positive virus outcomes have been confirmed with polymerase chain response. For EBV, EBV encoded RNA ISH was carried out. Differences in 5-year survival between virus constructive and detrimental tumors have been decided by log rank evaluation.

A Broad Safety Assessment of the 9-Valent Human Papillomavirus Vaccine

Split-type electrochemiluminescent gene assay platform based mostly on gold nanocluster probe for human papillomavirus prognosis

Persistent high-risk human papillomavirus (HPV) an infection is the main trigger of cervical most cancers. Efficient detection of HPV16 E7 is critical for early prognosis and remedy of the illness. Here, a novel and high-performance Au nanocluster (AuNC) probe-based split-type electrochemiluminescent (ECL) assay platform has been established to detect these oncogenes, during which the nucleic acid hybridization assay and the ECL measurements are carried out independently. The proposed method combines superior magnetic nanobead enrichment and separation know-how, particular nucleic acid hybridization know-how, and high-efficiency AuNC probe ECL technique, and reveals wonderful benefits.

Human papillomavirus antibody(IgM) Elisa Kit

EK714259 96 Wells
EUR 0.44

Human papillomavirus antibody(IgM) ELISA Kit

EK0267 96 tests
EUR 789

Human papillomavirus antibody(IgM) ELISA Kit

CSB-E08783h-24T 1 plate of 24 wells
EUR 198
Description: Quantitative sandwich ELISA kit for measuring Human papillomavirus antibody (IgM) in samples from serum, plasma, cell culture supernates, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.

Human papillomavirus antibody(IgM) ELISA Kit

1-CSB-E08783h
  • Ask for price
  • Ask for price
  • Ask for price
  • 1 plate of 96 wells
  • 10 plates of 96 wells each
  • 5 plates of 96 wells each
Description: Quantitative sandwich ELISA kit for measuring Human papillomavirus antibody(IgM) in samples from serum, plasma, cell culture supernates, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.

Human Papillomavirus 18 Antibody (Anti-HPV-18) ELISA Kit

abx055803-100g 100 µg Ask for price

Human Papillomavirus 18 Antibody (Anti-HPV-18) ELISA Kit

abx055803-10g 10 µg
EUR 493.75

Human Papillomavirus 18 Antibody (Anti-HPV-18) ELISA Kit

abx055803-50g 50 µg Ask for price

ELISA kit for Human papillomavirus antibody (IgG)

EK0266 96 tests
EUR 854.4
Description: Enzyme-linked immunosorbent assay kit for quantification of Human papillomavirus antibody (IgG) in samples from serum, plasma, tissue homogenates and other biological fluids.

Human Papillomavirus 16 (HPV-16) Antibody

abx021894-400l 400 µl Ask for price

Human Papillomavirus 16 (HPV-16) Antibody

abx021894-80l 80 µl
EUR 737.5

Human Papillomavirus 16 (HPV-16) Antibody

abx021895-400l 400 µl Ask for price

Human Papillomavirus 16 (HPV-16) Antibody

abx021895-80l 80 µl
EUR 700

Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody

BNC811058-100 100uL
EUR 238.8
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), CF680R conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody

BNC811058-500 500uL
EUR 652.8
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), CF680R conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody

BNC801058-100 100uL
EUR 238.8
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), CF680 conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody

BNC801058-500 500uL
EUR 652.8
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), CF680 conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody

BNC431058-100 100uL
EUR 238.8
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), CF543 conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody

BNC431058-500 500uL
EUR 652.8
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), CF543 conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody

BNC051058-100 100uL
EUR 238.8
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), CF405M conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody

BNC051058-500 500uL
EUR 652.8
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), CF405M conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody

BNC551058-100 100uL
EUR 238.8
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), CF555 conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody

BNC551058-500 500uL
EUR 652.8
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), CF555 conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody

BNC701058-100 100uL
EUR 238.8
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), CF770 conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody

BNC701058-500 500uL
EUR 652.8
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), CF770 conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody

BNC611058-100 100uL
EUR 238.8
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), CF660R conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody

BNC611058-500 500uL
EUR 652.8
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), CF660R conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody

BNCP1058-250 250uL
EUR 459.6
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), PerCP conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody

BNCR1058-250 250uL
EUR 459.6
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), RPE conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody

BNCA1058-250 250uL
EUR 459.6
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), APC conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody

BNCH1058-100 100uL
EUR 238.8
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody

BNCH1058-500 500uL
EUR 652.8
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody

BNCAP1058-100 100uL
EUR 238.8
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(HPV16/1058) Antibody

BNCAP1058-500 500uL
EUR 652.8
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(HPV16/1058), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 L1 (HPV-16 L1) Antibody

abx021897-400l 400 µl Ask for price

Human Papillomavirus 16 L1 (HPV-16 L1) Antibody

abx021897-80l 80 µl
EUR 762.5

Human Papillomavirus 16 L1 (HPV-16 L1) Antibody

abx021898-400l 400 µl Ask for price

Human Papillomavirus 16 L1 (HPV-16 L1) Antibody

abx021898-80l 80 µl
EUR 800

Human papillomavirus

PCR-H454-PCRH45448D PCR-H454-48D
EUR 230

Human papillomavirus

PCR-H454-PCRH45496D PCR-H454-96D
EUR 312

Human papillomavirus

Oneq-H454-OneqH454100D Oneq-H454-100D
EUR 515

Human papillomavirus

Oneq-H454-OneqH454150D Oneq-H454-150D
EUR 594

Human papillomavirus

Oneq-H454-OneqH45450D Oneq-H454-50D
EUR 413

Human papillomavirus 6 antibody IgG (HPV6-IgG)ELISA Kit

SL2795Hu 96 Tests
EUR 468

Mouse Human papillomavirus(HPV) ELISA Kit

NSL1497m 96 Test
EUR 528

ELISA kit for Human Papillomavirus L1 antibody (HPV-L1 Ab)

KTE62897-48T 48T
EUR 424.8
Description: Quantitative sandwich ELISA for measuring Human Papillomavirus L1 antibody (HPV-L1 Ab) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Human Papillomavirus L1 antibody (HPV-L1 Ab)

KTE62897-5platesof96wells 5 plates of 96 wells
EUR 2702.4
Description: Quantitative sandwich ELISA for measuring Human Papillomavirus L1 antibody (HPV-L1 Ab) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Human Papillomavirus L1 antibody (HPV-L1 Ab)

KTE62897-96T 96T
EUR 686.4
Description: Quantitative sandwich ELISA for measuring Human Papillomavirus L1 antibody (HPV-L1 Ab) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody

BNC810502-100 100uL
EUR 238.8
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), CF680R conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody

BNC810502-500 500uL
EUR 652.8
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), CF680R conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody

BNC430502-100 100uL
EUR 238.8
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), CF543 conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody

BNC430502-500 500uL
EUR 652.8
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), CF543 conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody

BNC050502-100 100uL
EUR 238.8
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), CF405M conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody

BNC050502-500 500uL
EUR 652.8
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), CF405M conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody

BNC550502-100 100uL
EUR 238.8
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), CF555 conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody

BNC550502-500 500uL
EUR 652.8
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), CF555 conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody

BNC800502-100 100uL
EUR 238.8
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), CF680 conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody

BNC800502-500 500uL
EUR 652.8
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), CF680 conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody

BNC610502-100 100uL
EUR 238.8
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), CF660R conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody

BNC610502-500 500uL
EUR 652.8
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), CF660R conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody

BNC700502-100 100uL
EUR 238.8
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), CF770 conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody

BNC700502-500 500uL
EUR 652.8
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), CF770 conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody

BNCP0502-250 250uL
EUR 459.6
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), PerCP conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody

BNCR0502-250 250uL
EUR 459.6
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), RPE conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody

BNCA0502-250 250uL
EUR 459.6
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), APC conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody

BNCAP0502-100 100uL
EUR 238.8
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody

BNCAP0502-500 500uL
EUR 652.8
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody

BNCH0502-100 100uL
EUR 238.8
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Human Papillomavirus 16 (HPV16)(CAMVIR-1) Antibody

BNCH0502-500 500uL
EUR 652.8
Description: Primary antibody against Human Papillomavirus 16 (HPV16)(CAMVIR-1), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Human papillomavirus 18 antibody IgG (HPV18-IgG)ELISA Kit

SL2639Hu 96 Tests
EUR 468

Human papillomavirus 11 antibody IgG (HPV11-IgG) ELISA Kit

SL3132Hu 96 Tests
EUR 468

Human papillomavirus 6

PCR-H461-PCRH46148D PCR-H461-48D
EUR 230

Human papillomavirus 6

PCR-H461-PCRH46196D PCR-H461-96D
EUR 312

Human papillomavirus 11

PCR-H462-PCRH46248D PCR-H462-48D
EUR 230

Human papillomavirus 11

PCR-H462-PCRH46296D PCR-H462-96D
EUR 312

Human papillomavirus 16

PCR-H463-PCRH46348D PCR-H463-48D
EUR 230

Human papillomavirus 16

PCR-H463-PCRH46396D PCR-H463-96D
EUR 312

Human papillomavirus 18

PCR-H464-PCRH46448D PCR-H464-48D
EUR 230

Human papillomavirus 18

PCR-H464-PCRH46496D PCR-H464-96D
EUR 312

Human papillomavirus 30

PCR-H465-PCRH46548D PCR-H465-48D
EUR 230

Human papillomavirus 30

PCR-H465-PCRH46596D PCR-H465-96D
EUR 312

Human papillomavirus 31

PCR-H466-PCRH46648D PCR-H466-48D
EUR 230

Human papillomavirus 31

PCR-H466-PCRH46696D PCR-H466-96D
EUR 312

Human papillomavirus 33

PCR-H467-PCRH46748D PCR-H467-48D
EUR 230

Human papillomavirus 33

PCR-H467-PCRH46796D PCR-H467-96D
EUR 312

Human papillomavirus 35

PCR-H468-PCRH46848D PCR-H468-48D
EUR 230

Human papillomavirus 35

PCR-H468-PCRH46896D PCR-H468-96D
EUR 312

Human papillomavirus 39

PCR-H469-PCRH46948D PCR-H469-48D
EUR 230

Human papillomavirus 39

PCR-H469-PCRH46996D PCR-H469-96D
EUR 312

Human papillomavirus 40

PCR-H470-PCRH47048D PCR-H470-48D
EUR 230

Human papillomavirus 40

PCR-H470-PCRH47096D PCR-H470-96D
EUR 312

Human papillomavirus 42

PCR-H471-PCRH47148D PCR-H471-48D
EUR 230

Human papillomavirus 42

PCR-H471-PCRH47196D PCR-H471-96D
EUR 312

Human papillomavirus 43

PCR-H472-PCRH47248D PCR-H472-48D
EUR 230

Human papillomavirus 43

PCR-H472-PCRH47296D PCR-H472-96D
EUR 312

Human papillomavirus 44

PCR-H473-PCRH47348D PCR-H473-48D
EUR 230

Human papillomavirus 44

PCR-H473-PCRH47396D PCR-H473-96D
EUR 312

Human papillomavirus 45

PCR-H474-PCRH47448D PCR-H474-48D
EUR 230

Human papillomavirus 45

PCR-H474-PCRH47496D PCR-H474-96D
EUR 312

Human papillomavirus 51

PCR-H475-PCRH47548D PCR-H475-48D
EUR 230

Human papillomavirus 51

PCR-H475-PCRH47596D PCR-H475-96D
EUR 312

Human papillomavirus 52

PCR-H476-PCRH47648D PCR-H476-48D
EUR 230

Human papillomavirus 52

PCR-H476-PCRH47696D PCR-H476-96D
EUR 312

Human papillomavirus 56

PCR-H477-PCRH47748D PCR-H477-48D
EUR 230

Human papillomavirus 56

PCR-H477-PCRH47796D PCR-H477-96D
EUR 312

Human papillomavirus 58

PCR-H478-PCRH47848D PCR-H478-48D
EUR 230

Human papillomavirus 58

PCR-H478-PCRH47896D PCR-H478-96D
EUR 312

Human papillomavirus 59

PCR-H479-PCRH47948D PCR-H479-48D
EUR 230

Human papillomavirus 59

PCR-H479-PCRH47996D PCR-H479-96D
EUR 312

Human papillomavirus 6

Oneq-H461-OneqH461100D Oneq-H461-100D
EUR 515

Human papillomavirus 6

Oneq-H461-OneqH461150D Oneq-H461-150D
EUR 594

Human papillomavirus 6

Oneq-H461-OneqH46150D Oneq-H461-50D
EUR 413

Human papillomavirus 11

Oneq-H462-OneqH462100D Oneq-H462-100D
EUR 515

Human papillomavirus 11

Oneq-H462-OneqH462150D Oneq-H462-150D
EUR 594

Human papillomavirus 11

Oneq-H462-OneqH46250D Oneq-H462-50D
EUR 413

Human papillomavirus 16

Oneq-H463-OneqH463100D Oneq-H463-100D
EUR 515

Human papillomavirus 16

Oneq-H463-OneqH463150D Oneq-H463-150D
EUR 594

Human papillomavirus 16

Oneq-H463-OneqH46350D Oneq-H463-50D
EUR 413

Human papillomavirus 18

Oneq-H464-OneqH464100D Oneq-H464-100D
EUR 515

Human papillomavirus 18

Oneq-H464-OneqH464150D Oneq-H464-150D
EUR 594

Human papillomavirus 18

Oneq-H464-OneqH46450D Oneq-H464-50D
EUR 413

Human papillomavirus 30

Oneq-H465-OneqH465100D Oneq-H465-100D
EUR 515

Human papillomavirus 30

Oneq-H465-OneqH465150D Oneq-H465-150D
EUR 594

Human papillomavirus 30

Oneq-H465-OneqH46550D Oneq-H465-50D
EUR 413

Human papillomavirus 31

Oneq-H466-OneqH466100D Oneq-H466-100D
EUR 515

Human papillomavirus 31

Oneq-H466-OneqH466150D Oneq-H466-150D
EUR 594

Human papillomavirus 31

Oneq-H466-OneqH46650D Oneq-H466-50D
EUR 413

Human papillomavirus 33

Oneq-H467-OneqH467100D Oneq-H467-100D
EUR 515

Human papillomavirus 33

Oneq-H467-OneqH467150D Oneq-H467-150D
EUR 594

Human papillomavirus 33

Oneq-H467-OneqH46750D Oneq-H467-50D
EUR 413

Human papillomavirus 35

Oneq-H468-OneqH468100D Oneq-H468-100D
EUR 515

Human papillomavirus 35

Oneq-H468-OneqH468150D Oneq-H468-150D
EUR 594

Human papillomavirus 35

Oneq-H468-OneqH46850D Oneq-H468-50D
EUR 413

Human papillomavirus 39

Oneq-H469-OneqH469100D Oneq-H469-100D
EUR 515

Human papillomavirus 39

Oneq-H469-OneqH469150D Oneq-H469-150D
EUR 594

First, the split-type ECL sensing platform can successfully keep away from interference from organic samples and adequately makes use of the ECL effectivity of the AuNC probe. Furthermore, the ultrahigh sensitivity assay of HPV DNA will be achieved with none complicated nucleic acid amplification method. Taking benefit of the above deserves of split-type detection, the ECL DNA sensor achieved ideally suited low detection of 6.eight aM and a large dynamic vary bridging 10 orders of magnitude HPV16 E7. Furthermore, along with its favorable and highly effective specificity, excessive sensitivity, and good selectivity, this technique might detect HPV16 E7 DNA in human samples, which confirmed nice consistency with the FDA-approved method (Hybrid seize 2, HC2).